Oral fluoropyrimidines: are they the equivalent of parenteral infusional 5-fluorouracil?
Lokich
J
J
Neoplastic Disease, The Cancer Center of Boston in Boston, Massachusetts, USA.
D000284:Administration, Oral; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D000069287:Capecitabine; D003841:Deoxycytidine / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D005472:Fluorouracil / Q000008:administration & dosage*; D006801:Humans; D007262:Infusions, Intravenous; D005641:Tegafur / Q000008:administration & dosage*; D014498:Uracil / Q000008:administration & dosage* / Q000031:analogs & derivatives*
D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D005641:Tegafur; C073482:eniluracil; D014498:Uracil; D000069287:Capecitabine; D005472:Fluorouracil